Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricINCYIncyteBNTXBiontech SEMRNAModerna
Snapshot
Price$126.97$101.29$182.52
Market cap$23.35B$24.67B$31.65B
Valuation
P/E17.7x——
Forward P/E12.7x——
Growth
Revenue growth21.5%-11.8%-30.0%
EPS growth2455.3%——
Profitability
Net margin26.7%-34.0%-143.6%
ROE29.2%-6.7%-36.7%
Balance sheet & cash
Debt / equity0.01x0.01x0.07x
Free cash flow yield2.2%13.6%-13.6%
Dividend yield———
Verdict
Investment ratingStrong· 86Weak· 31Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearINCYtoday $127BNTXtoday $101MRNAtoday $183
2027$2,433.36 – $3,568.92+2711% CAGR$77.49 – $113.65+12% CAGR$139.63 – $204.79+12% CAGR
2028$62,179.84 – $91,197.09+2580% CAGR$79.04 – $115.92+7% CAGR$142.42 – $208.88+7% CAGR
2029$1,588,887.57 – $2,330,368.43+2538% CAGR$80.62 – $118.24+5% CAGR$145.27 – $213.06+5% CAGR
2030$40,601,002.88 – $59,548,137.55+2517% CAGR$82.23 – $120.60+4% CAGR$148.17 – $217.32+4% CAGR
2031$1,037,481,486.63 – $1,521,639,513.73+2504% CAGR$83.87 – $123.02+4% CAGR$151.14 – $221.67+4% CAGR
5-yr CAGR2312.4% – 2504.5%-3.7% – 4.0%-3.7% – 4.0%